Interactions between subunits of protein kinase CK2 and their protein substrates influences its sensitivity to specific inhibitors

被引:8
作者
Janeczko, Monika [1 ]
Maslyk, Maciej [1 ]
Szyszka, Ryszard [1 ]
Baier, Andrea [1 ]
机构
[1] John Paul II Catholic Univ Lublin, Dept Mol Biol, Inst Biotechnol, PL-20718 Lublin, Poland
关键词
Yeast; Protein kinase CK2 isoforms; ATP-competitive inhibitors; MOLECULAR-FORMS; PHOSPHORYLATION; PURIFICATION; BETA;
D O I
10.1007/s11010-011-0951-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Five isoforms of CK2 may exist simultaneously in yeast cells: free catalytic subunits CK2 alpha', CK2 alpha and three holoenzymatic structures composed of alpha alpha'beta beta', alpha(2)beta beta' and alpha'(2)beta beta'. Each isolated and purified form exhibits properties typical for CK2, but they differ in substrate specificity as well as in sensitivity to specific modulators. All five isoforms of protein kinase CK2 from Saccharomyces cerevisiae were examined for their binding capacity with ATP/GTP and two commonly used ATP-competitive inhibitors TBB and TBI. Enzymes were tested with protein substrates differently interacting with CK2 subunits: Elf1, Fip1, Svf1, P2B and synthetic peptide. Obtained results show that K (m) for ATP varies from 2.4-53 mu M for Elf1/CK2 alpha' and Svf1/CK2 alpha, respectively. Similar differences can be seen in case when GTP was used as phosphate donor. The inhibitory effect depends on composition of CK2/substrate complexes. Highest sensitivity to TBB shows all complexes containing alpha alpha'(II2)-I-2' isoform with K (i) values between 0.2 and 1.1 mu M. The prospect that TBB and TBI could be utilized to discriminate between different molecular forms of CK2 in yeast cells was examined. Both inhibitors, TBB as well as TBI, decreases cell growth to extents devoting interactions with different CK2 isoforms present in the cell but the presence of beta/beta'-dimer has a high importance towards sensitivity. Conceivably, a given inhibitor concentration can inhibit only selected CK2-mediated processes in the cell.
引用
收藏
页码:121 / 126
页数:6
相关论文
共 29 条
[1]   Targeting CK2 for cancer therapy [J].
Ahmad, KA ;
Wang, GX ;
Slaton, J ;
Unger, G ;
Ahmed, K .
ANTI-CANCER DRUGS, 2005, 16 (10) :1037-1043
[2]   Joining the cell survival squad: an emerging role for protein kinase CK2 [J].
Ahmed, K ;
Gerber, DA ;
Cochet, C .
TRENDS IN CELL BIOLOGY, 2002, 12 (05) :226-230
[3]   Halogenated benzimidazoles and benzotriazoles as inhibitors of the NTPase/helicase activities of hepatitis C and related viruses [J].
Borowski, P ;
Deinert, J ;
Schalinski, S ;
Bretner, M ;
Ginalski, K ;
Kulikowski, T ;
Shugar, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270 (08) :1645-1653
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   CK2, a protein kinase of the next millennium [J].
Dobrowolska, G ;
Lozeman, FJ ;
Li, DX ;
Krebs, EG .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1999, 191 (1-2) :3-12
[6]  
Domanska K, 2005, ACTA BIOCHIM POL, V52, P947
[7]   Subcellular localization of protein kinase CK2 - A key to its function? [J].
Faust, M ;
Montenarh, M .
CELL AND TISSUE RESEARCH, 2000, 301 (03) :329-340
[8]  
Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO
[9]  
2-N
[10]   Characterization of protein kinase CK2 from Trypanosoma brucei [J].
Jensen, Bryan C. ;
Kifer, Charles T. ;
Brekken, Deirdre L. ;
Randall, Amber C. ;
Wang, Qin ;
Drees, Becky L. ;
Parsons, Marilyn .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2007, 151 (01) :28-40